Products tagged with Theranostic
Lutetium-177 (Lu-177) is being widely used as a promising radionuclide for targeted therapy and is emerging as a game-changing theranostic isotope for the treatment of neuroendocrine tumors, metastatic castration-resistant prostate cancer (mCRPC) along with its development for new carrier molecules that can provide selective targeting for tumor sites.
Iodine-131 (I-131) is a radioactive isotope of iodine that is used in nuclear medicine procedures to diagnose and treat conditions of the thyroid, including hyperthyroidism and thyroid cancer.
